Work

Treatment patterns and clinical outcomes in HER2-low metastatic breast cancer, 2018–2023: A retrospective observational study.

Year: 2024

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2024.20.10_suppl.398

Authors: Erica L. Mayer, Simon M. Collin, Sam Hillman, Luis C. Berrocal-Almanza, Joseph A. Sparano, Clara Lam

Institutions: Dana-Farber Cancer Institute, AstraZeneca (United Kingdom), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, AstraZeneca (United States)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402987354

Cites:

Cited by:

Related to: 10